Lakefront Biotherapeutics (LKFT)

NASDAQ:LKFT

US Market

LKFT

Lakefront Biotherapeutics

RESEARCH TOOLSreports

Want to see LKFT full AI Analyst Report?

Lakefront Biotherapeutics (LKFT) Ownership - Who Owns Lakefront Biotherapeutics?

549 Followers

Lakefront Biotherapeutics (LKFT) Ownership Overview

1.70% Mutual Funds

41.89% Other Institutional Investors

0.66% ETFs

55.74% Public Companies and

Individual Investors

The ownership structure of Lakefront Biotherapeutics (LKFT) stock is a mix of institutional, retail, and individual investors. Approximately 44.26% of the company’s stock is owned by Institutional Investors, and 55.74% is owned by Public Companies and Individual Investors.

The ownership structure of Lakefront Biotherapeutics (LKFT) stock is a mix of institutional, retail, and individual investors. Approximately 42.56% of the company’s stock is owned by Institutional Investors, 1.70% is owned by Insiders, and 55.74% is owned by Public Companies and Individual Investors.

Recent Hedge Fund Trading Activity

Date	Firm	Activity	Value
Mar 31, 2024	Manning & Napier Advisors Llc	xxxxxxxxxxxxx	$750

Show More Hedge Fund Trading Activity >

Top Shareholders

Holder	# of Shares	Type	% Holding	Value
	714,747	Institution	1.08%	21,070,742
	309,018	Institution	0.47%	9,109,851
	108,500	Institution	0.16%	3,198,580
	94,152	Institution	0.14%	2,775,601
	94,113	Institution	0.14%	2,774,451
	79,669	Institution	0.12%	2,348,642
	64,407	Institution	0.10%	1,898,718
Theofanis Kolokotrones	50,500	Institution	0.08%	1,488,740
	38,679	Institution	0.06%	1,140,257
Eric Andersen	32,000	Institution	0.05%	943,360

Top Mutual Fund Holders

Holder	# of Shares	Type	% Holding	Value
	714,747	Institution	1.08%	21,070,742
	108,500	Institution	0.16%	3,198,580
	94,152	Institution	0.14%	2,775,601
	94,113	Institution	0.14%	2,774,451
	79,669	Institution	0.12%	2,348,642
	22,789	Institution	0.03%	671,820
	7,851	Institution	0.01%	231,447
	1,419	Institution	<0.01%	41,832

Top ETF Holders

Holder	# of Shares	Type	% Holding	Value
iShares Biotechnology ETF	287,072	Institution	0.44%	8,327,959
ALPS Medical Breakthroughs ETF	64,407	Institution	0.10%	1,868,447
Avantis International Equity ETF	30,449	Institution	0.05%	884,543
ActivePassive International Equity ETF	18,401	Institution	0.03%	534,549
iShares NASDAQ US Biotechnology UCITS ETF	10,973	Institution	0.02%	317,559
Avantis International Small Cap Equity ETF	7,042	Institution	0.01%	204,288
Invesco NASDAQ Future Gen 200 ETF	3,712	Institution	<0.01%	107,685
VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD	1,358	Institution	<0.01%	39,450
Invesco Nasdaq Biotechnology ETF	763	Institution	<0.01%	22,135
American Century ICAV - Avantis Global Equity UCITS ETF Accum- USD	569	Institution	<0.01%	16,529

FAQ

Who Owns Lakefront Biotherapeutics (LKFT)?

Currently, no data Available

What percentage of Lakefront Biotherapeutics (LKFT) stock is held by institutional investors?

According to the latest TipRanks data, approximately 41.89% of Lakefront Biotherapeutics (LKFT) stock is held by institutional investors.

What percentage of Lakefront Biotherapeutics (LKFT) stock is held by retail investors?

According to the latest TipRanks data, approximately 55.74% of Lakefront Biotherapeutics (LKFT) stock is held by retail investors.

Who owns the most shares of Lakefront Biotherapeutics (LKFT)?

COLUMBIA FUNDS SERIES TRUST owns the most shares of Lakefront Biotherapeutics (LKFT).

What is the significance of the ownership structure for a publicly traded company?

The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.